乌帕替尼-话题@MedSci

#乌帕替尼#

16篇内容 | 2107人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1418843, encodeId=e5bf14188434c, content=<a href='/topic/show?id=be872334551' target=_blank style='color:#2F92EE;'>#乌帕替尼#</a>, objectTitle=三个适应症连续获批！免疫创新药「乌帕替尼缓释片」开启银屑病关节炎靶向治疗新时代！, objectType=article, longId=298947, objectId=140429894ed8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=140429894ed8, replyNumber=0, likeNumber=113, createdTime=2022-02-18, rootId=0, userName=wodejia-dayu, userId=46123431463, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=140429894ed8, moduleTitle=三个适应症连续获批！免疫创新药「乌帕替尼缓释片」开启银屑病关节炎靶向治疗新时代！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=140429894ed8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418839, encodeId=c5d714188396b, content=<a href='/topic/show?id=be872334551' target=_blank style='color:#2F92EE;'>#乌帕替尼#</a>, objectTitle=Ann Rheum Dis：接受乌帕替尼治疗的类风湿性关节炎患者带状疱疹发病率和危险因素, objectType=article, longId=218375, objectId=d1792183e5ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1792183e5ae, replyNumber=0, likeNumber=107, createdTime=2021-10-12, rootId=0, userName=wodejia-dayu, userId=46123431463, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1792183e5ae, moduleTitle=Ann Rheum Dis：接受乌帕替尼治疗的类风湿性关节炎患者带状疱疹发病率和危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1792183e5ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418838, encodeId=3fcb14188383b, content=<a href='/topic/show?id=be872334551' target=_blank style='color:#2F92EE;'>#乌帕替尼#</a>, objectTitle=Ann Rheum Dis：类风湿性关节炎换用阿达木单抗或乌帕替尼治疗的疗效和安全性, objectType=article, longId=208557, objectId=2da320855e15, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2da320855e15, replyNumber=0, likeNumber=143, createdTime=2021-03-19, rootId=0, userName=wodejia-dayu, userId=46123431463, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2da320855e15, moduleTitle=Ann Rheum Dis：类风湿性关节炎换用阿达木单抗或乌帕替尼治疗的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2da320855e15)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418837, encodeId=9cd4141883e7a, content=<a href='/topic/show?id=be872334551' target=_blank style='color:#2F92EE;'>#乌帕替尼#</a>, objectTitle=Ann Rheum Dis：使用乌帕替尼治疗类风湿性关节炎的安全性, objectType=article, longId=207551, objectId=9eac20e551fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9eac20e551fd, replyNumber=0, likeNumber=106, createdTime=2021-02-26, rootId=0, userName=wodejia-dayu, userId=46123431463, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9eac20e551fd, moduleTitle=Ann Rheum Dis：使用乌帕替尼治疗类风湿性关节炎的安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9eac20e551fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418836, encodeId=efca1418836e6, content=<a href='/topic/show?id=be872334551' target=_blank style='color:#2F92EE;'>#乌帕替尼#</a>, objectTitle=Ann Rheum Dis：乌帕替尼治疗类风湿性关节炎的安全性, objectType=article, longId=203275, objectId=aa6f2032e594, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa6f2032e594, replyNumber=0, likeNumber=107, createdTime=2020-11-13, rootId=0, userName=wodejia-dayu, userId=46123431463, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa6f2032e594, moduleTitle=Ann Rheum Dis：乌帕替尼治疗类风湿性关节炎的安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa6f2032e594)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418835, encodeId=ee2b141883563, content=<a href='/topic/show?id=be872334551' target=_blank style='color:#2F92EE;'>#乌帕替尼#</a>, objectTitle=乌帕替尼获突破性疗法认定, objectType=article, longId=128339, objectId=314a1283390e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=314a1283390e, replyNumber=0, likeNumber=73, createdTime=2018-02-01, rootId=0, userName=wodejia-dayu, userId=46123431463, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=314a1283390e, moduleTitle=乌帕替尼获突破性疗法认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=314a1283390e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

乌帕替尼

2020-05-29

wodejia-dayu (审核中...)

前往app查看评论内容

#乌帕替尼#

三个适应症连续获批！免疫创新药「乌帕替尼缓释片」开启银屑病关节炎靶向治疗新时代！

2022-02-18

wodejia-dayu (审核中...)

前往app查看评论内容

#乌帕替尼#

Ann Rheum Dis：接受乌帕替尼治疗的类风湿性关节炎患者带状疱疹发病率和危险因素

2021-10-12

wodejia-dayu (审核中...)

前往app查看评论内容

#乌帕替尼#

Ann Rheum Dis：类风湿性关节炎换用阿达木单抗或乌帕替尼治疗的疗效和安全性

2021-03-19

wodejia-dayu (审核中...)

前往app查看评论内容

#乌帕替尼#

Ann Rheum Dis：使用乌帕替尼治疗类风湿性关节炎的安全性

2021-02-26

wodejia-dayu (审核中...)

前往app查看评论内容

#乌帕替尼#

Ann Rheum Dis：乌帕替尼治疗类风湿性关节炎的安全性

2020-11-13

wodejia-dayu (审核中...)

前往app查看评论内容

#乌帕替尼#

乌帕替尼获突破性疗法认定

2018-02-01

科室
- - 订阅+
  - 更多科室
工具
服务